CompanyRNACNasdaqFrederick, MD

Cartesian Therapeutics

Cartesian Therapeutics develops CAR-T cell therapies for autoimmune diseases.

SEC EDGAR ClinicalTrials.gov cartesiantherapeutics.com

8-KSep 29Latest SEC filing

Aug 6Latest story

August 2026

Cartesian reports Q2 2026 results, four clinical readouts expected within a year

Aug 6Quarterly updateCartesian Therapeutics